Plus: The intergenerational fight to remove race from kidney disease calculators

September 5, 2024 Check out STAT+

Sponsored By

Matthew Christiansen/U.S. National Science Foundation In a first, living mice are made transparent Researchers use special dye to see through tissue. Technique would be noninvasive and reversible, but more research needed on safety, efficacy, benefits. By Anil Oza STAT+ | Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target Novo Nordisk and Eli Lilly, makers of blockbuster GLP-1 drugs, test amylin hormone receptor treatments in pursuit of fewer side effects. By Elaine Chen and Allison DeAngelis STAT+ | Alnylam versus BridgeBio: The ATTR-CM debate Alnylam Pharmaceuticals executives instigated a dustup when they asserted a cardiologist made mistakes during a discussion about its heart treatment. By Adam Feuerstein Inside the bruising battle to purge race from a kidney disease calculator Kidney specialists now acknowledge millions of Black patients may have been undertreated and even denied transplants because of a race-adjusted test. By Usha Lee McFarling and Katie Palmer STAT+ | U.K. charities give $36 million to start new drugs for childhood tumors  The goal is to advance new molecules to a "drug candidate" stage, after which a company could take and advance it into early human trials. By Jason Mast Summit's upcoming cancer results, Recursion's mixed data, and the next big obesity target We discuss an upcoming presentation from Summit Therapeutics, mixed data from Recursion, and amylin obesity drugs. By Elaine Chen, Allison DeAngelis, and Adam Feuerstein Daniel Leal - WPA Pool/Getty Images Youth vaping continues its tumble from a Juul-fueled high Public health officials are celebrating a sharp decline in e-cigarette use among kids in the U.S. By Lizzy Lawrence

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser